{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:14:10Z","timestamp":1786115650019,"version":"build-2736575974"},"reference-count":12,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Primary gastric melanoma is a rare clinical finding. Its diagnosis can be challenging due to the complex tissue structure of the stomach and the diverse morphology of melanoma cells, which contribute to the increased likelihood of misdiagnosis. Here we report a 69-year-old female patient with primary gastric melanoma, initially misdiagnosed as \u201cgastric adenocarcinoma\u201d. The patient initially received two cycles of neoadjuvant therapy with Tegeo in combination with oxaliplatin (SOX). Unfortunately, the response was not satisfactory. In order to guide further treatment decisions, immunohistochemistry (IHC) and next-generation sequencing (NGS) were conducted. Immunohistochemistry: CK (-), CK8\/18 (-), Vimentin (+), CD56 (-), CgA (-), Syn (-), ALK (-), CD30 (-), S-100 (+), INI1 (expression), CD43 (-), CD3 (-), CD20 (-), Brg-1 (expression), CD117 (-), DOG-1 (-), CD34 (-), HMB-45 (+), melan-A (+), Her-2 (-). NGS showed no significant abnormalities in HER-2 and wild type in the range of BRAF gene detection. Through a Multidisciplinary Team (MDT) consultation, she was finally diagnosed with \u201cprimary gastric malignant melanoma\u201d. Despite the disease progressing after first-line chemotherapy with temozolomide, cisplatin, and bevacizumab, a second-line treatment with albumin paclitaxel, carboplatin, and bevacizumab resulted in a sustained partial remission (PR). The patient\u2019s condition was stable during the follow-up period. As far as we know, this is a rare case of primary gastric malignant melanoma which received persistent PR after second-line treatment. Combined with the pathological manifestations of MM and recent clinical studies, the pathological features and treatment of primary gastric malignant melanoma were discussed.<\/jats:p>","DOI":"10.3389\/fonc.2026.1893937","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T04:25:28Z","timestamp":1785990328000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Warning of the poor effect of chemotherapy: primary gastric malignant melanoma misdiagnosed as \u201cgastric adenocarcinoma\u201d: a case report and literature review"],"prefix":"10.3389","volume":"16","author":[{"given":"Yuting","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Oncology, First Affiliated Hospital of Dalian Medical University","place":["Dalian, Liaoning, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruzhu","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Oncology, First Affiliated Hospital of Dalian Medical University","place":["Dalian, Liaoning, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianshu","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Oncology, First Affiliated Hospital of Dalian Medical University","place":["Dalian, Liaoning, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwen","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Oncology, First Affiliated Hospital of Dalian Medical University","place":["Dalian, Liaoning, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Oncology, First Affiliated Hospital of Dalian Medical University","place":["Dalian, Liaoning, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiguo","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Oncology, First Affiliated Hospital of Dalian Medical University","place":["Dalian, Liaoning, China"]},{"name":"Institute of Integrated Traditional Chinese and Western Medicine, Dalian Medical University","place":["Dalian, Liaoning, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s40257-018-0373-6","article-title":"Unusual clinical presentations of Malignant melanoma: a review of clinical and histologic features with special emphasis on dermatoscopic findings","volume":"19","author":"Cabrera","year":"2018","journal-title":"Am J Clin Dermatol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdz411","article-title":"Cutaneous melanoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up\u2020","volume":"30","author":"Michielin","year":"2019","journal-title":"Ann Oncol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0560.2011.01808.x","article-title":"Amelanotic melanoma: a detailed morphologic analysis with clinicopathologic correlation of 75 cases","volume":"39","author":"Cheung","year":"2012","journal-title":"J Cutan Pathol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2010-0067","article-title":"Mucosal melanomas: a case-based review of the literature","volume":"15","author":"Seetharamu","year":"2010","journal-title":"Oncologist"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1682861","article-title":"Case report: S100-negative primary anorectal melanoma with elevated Ki67: a case for biology-driven radical resection despite early radiological staging","volume":"15","author":"Ren","year":"2025","journal-title":"Front Oncol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.05.044","article-title":"Genomic classification of cutaneous melanoma","volume":"161","year":"2015","journal-title":"Cell"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1097\/PRS.0000000000004571","article-title":"Malignant melanoma: diagnostic and management update","volume":"142","author":"Knackstedt","year":"2018","journal-title":"Plast Reconstr Surg"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-35431-x","article-title":"Neoadjuvant therapy with immune checkpoint blockade, antiangiogenesis, and chemotherapy for locally advanced gastric cancer","volume":"14","author":"Li","year":"2023","journal-title":"Nat Commun"},{"key":"B9","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ejca.2018.08.008","article-title":"The impact of effective systemic therapies on surgery for stage IV melanoma","volume":"103","author":"Smith","year":"2018","journal-title":"Eur J Cancer"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1163805","article-title":"Efficacy and safety of bevacizumab in patients with Malignant melanoma: a systematic review and PRISMA-compliant meta-analysis of randomized controlled trials and non-comparative clinical studies","volume":"14","author":"Han","year":"2023","journal-title":"Front Pharmacol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"112921","DOI":"10.1016\/j.ejca.2023.05.009","article-title":"Impact of second opinion pathology review in the diagnosis and management of atypical melanocytic lesions: a prospective study of the Italian Melanoma Intergroup (IMI) and EORTC Melanoma Group","volume":"189","author":"Massi","year":"2023","journal-title":"Eur J Cancer"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1097\/DAD.0000000000002225","article-title":"Aberrant expression of immunohistochemical markers in Malignant melanoma: a review","volume":"44","author":"Saliba","year":"2022","journal-title":"Am J Dermatopathol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1893937\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T04:25:28Z","timestamp":1785990328000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1893937\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,6]]},"references-count":12,"alternative-id":["10.3389\/fonc.2026.1893937"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1893937","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,6]]},"article-number":"1893937"}}